doctor on phone - Referrals for Clinicians

How We Work With Healthcare Providers

In our experience, patients are best served when the all members of the provider team work together and are fully informed. We value your expertise and welcome the opportunity to support you and your patients.

Submit your referral

We Work With:

Psychiatrists
Therapists
Psychologists
Neurologists
Pain Specialists
Primary Care Physicians
Coaches
Social Workers

Treatments for:

Depression
Anxiety
PTSD
Migraines & Headaches
CRPS & Chronic Pain
Immunity & Resilience

Our Services:

IV Ketamine
Spravato (intranasal Ketamine)
Stellate Ganglion Blocks (SGB)
IV Nutrients & Vitamins
IV NAD+
IV Glutathione
Ketamine Assisted Psychotherapy (KAP)
Life Skills Coaching

Let us help you support your patients!

We pride ourselves on offering our patients a process that is administratively efficient and clinically rigorous while maintining a high level of personalized care and attention.

Step 1: Confirm Your Patient's Interest

The first step is to confirm your patient's openness/interest in infusion therapies such as Ketamine, NAD+, Vitamins, Glutathione, etc. by having a conversation with the differences between Combination Infusion Therapy and conventional approaches to treating anxiety, depression and PTSD.

Step 2: Submit Online Patient Referral Form

If you believe your patient may be a good fit for guided Ketamine treatments, then please tell us a little about them so we may contact them. You can submit a Patient Referral Form here.

Step 3: Review Patient Care Plan With Us

Once we have spoken with your patient and received required documents, we will contact you to confirm/discuss our treatment plan. We value your input and experience and will work closely with you to ensure the best patient care possible.

Step 4: We Provide Ongoing Updates About Treatments and Progress

With your patient's consent, we will share treatment information with you in order to keep you informed of their progress.

Research Papers

Ketamine for Unipolar and Bipolar Depression

April 16, 2020

Due to unmet clinical needs for efficient drugs with a rapid onset of antidepressant effects, we aimed to evaluate the efficacy of single-dose ketamine in different subgroups of patients with major depression and establish whether repeated ketamine administration could be a viable strategy to maintain treatment gains.

Psychedelic Psychiatry’s Brave New World

April 2, 2020

After a legally mandated, decades-long global arrest of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding exciting results.

NAD+ in Aging: What It Is & Why You Need It

January 28, 2020

Rhonda Patrick explains what NAD+, why it is so important for aging and why it declines with age. She discusses some of the popular NAD+ boosters like nicotinamide riboside and nicotinamide mononucleotide, what animal and human data says and some concluding thoughts.